Cargando…

Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia

In the current COVID-19 pandemic context, proposing and validating effective treatments represents a major challenge. However, the scarcity of biologically relevant pre-clinical models of SARS-CoV-2 infection imposes a significant barrier for scientific and medical progress, including the rapid tran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pizzorno, Andrés, Padey, Blandine, Julien, Thomas, Trouillet-Assant, Sophie, Traversier, Aurélien, Errazuriz-Cerda, Elisabeth, Fouret, Julien, Dubois, Julia, Gaymard, Alexandre, Lescure, François-Xavier, Dulière, Victoria, Brun, Pauline, Constant, Samuel, Poissy, Julien, Lina, Bruno, Yazdanpanah, Yazdan, Terrier, Olivier, Rosa-Calatrava, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373044/ https://www.ncbi.nlm.nih.gov/pubmed/32835306 http://dx.doi.org/10.1016/j.xcrm.2020.100059

Ejemplares similares

Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model
por: Nicolas de Lamballerie, Claire, et al.
Publicado: (2020)

In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2
por: Pizzorno, Andrés, et al.
Publicado: (2020)

Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia
por: Nicolas de Lamballerie, Claire, et al.
Publicado: (2019)

Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy
por: Pizzorno, Andrés, et al.
Publicado: (2019)

Avian Cell Line DuckCelt(®)-T17 Is an Efficient Production System for Live-Attenuated Human Metapneumovirus Vaccine Candidate Metavac(®)
por: Chupin, Caroline, et al.
Publicado: (2021)

Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures
por: Pizzorno, Andrés, et al.
Publicado: (2019)

Influenza A viruses alter the stability and antiviral contribution of host E3-ubiquitin ligase Mdm2 during the time-course of infection
por: Pizzorno, Andrés, et al.
Publicado: (2018)

Strain-Dependent Impact of G and SH Deletions Provide New Insights for Live-Attenuated HMPV Vaccine Development
por: Dubois, Julia, et al.
Publicado: (2019)

In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses
por: Checkmahomed, Liva, et al.
Publicado: (2020)

Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro
por: Jonsdottir, Hulda R., et al.
Publicado: (2022)

Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
por: Lopez, Jonathan, et al.
Publicado: (2021)

Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
por: Lopez, Jonathan, et al.
Publicado: (2021)

Impact of Herpes simplex virus load and red blood cells in cerebrospinal fluid upon herpes simplex meningo-encephalitis outcome
por: Poissy, Julien, et al.
Publicado: (2012)

Effectiveness and cost of quick diagnostic tests to determine tetanus immunity in patients with a wound in french emergency departments
por: N'Diaye, Dieynaba S, et al.
Publicado: (2014)

La modulation de la signature transcriptomique de l’hôte infecté : une nouvelle stratégie thérapeutique dans les viroses graves ? Exemple de la grippe
por: Poissy, J., et al.
Publicado: (2016)

Nucleolin interacts with influenza A nucleoprotein and contributes to viral ribonucleoprotein complexes nuclear trafficking and efficient influenza viral replication
por: Terrier, Olivier, et al.
Publicado: (2016)

Immune Functional Assays, From Custom to Standardized Tests for Precision Medicine
por: Albert-Vega, Chloé, et al.
Publicado: (2018)

Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: Clinical and economic impact
por: Deuffic-Burban, Sylvie, et al.
Publicado: (2009)

Haemophilus influenzae causes cellular trans-differentiation in human bronchial epithelia
por: Glöckner, Michael, et al.
Publicado: (2021)

Influenza Viruses and mRNA Splicing: Doing More with Less
por: Dubois, Julia, et al.
Publicado: (2014)

Presence of circulating autoantibodies against bronchial epithelia cell in patients with nonatopic asthma.
por: Nahm, D. H., et al.
Publicado: (2000)

Exploring intrinsic variability between cultured nasal and bronchial epithelia in cystic fibrosis
por: Rodenburg, Lisa W., et al.
Publicado: (2023)

COVID-19 : les thérapeutiques
por: KHERABI, Yousra, et al.
Publicado: (2022)

P2Y(6) Receptor-Mediated Proinflammatory Signaling in Human Bronchial Epithelia
por: Hao, Yuan, et al.
Publicado: (2014)

Type 1 interferons as a potential treatment against COVID-19
por: Sallard, Erwan, et al.
Publicado: (2020)

Der f1 induces pyroptosis in human bronchial epithelia via the NLRP3 inflammasome
por: Tsai, Ying-Ming, et al.
Publicado: (2018)

440 Novel mechanism of transforming growth factor beta-1 signaling in human bronchial epithelia
por: Donovan, J., et al.
Publicado: (2022)

Easy-to-Build and Reusable Microfluidic Device for the Dynamic Culture of Human Bronchial Cystic Fibrosis Epithelia
por: Mazio, Claudia, et al.
Publicado: (2023)

Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus
por: Terrier, Olivier, et al.
Publicado: (2021)

Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort
por: Néant, Nadège, et al.
Publicado: (2021)

Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists
por: Bouadma, Lila, et al.
Publicado: (2020)

Patient-centered approach to the management of drug-resistant tuberculosis in France: How far off the mark are we?
por: Kherabi, Yousra, et al.
Publicado: (2022)

TRPV4-Mediated Calcium Influx into Human Bronchial Epithelia upon Exposure to Diesel Exhaust Particles
por: Li, Jinju, et al.
Publicado: (2011)

Differentiation of bronchial epithelial spheroids in the presence of IL‐13 recapitulates characteristic features of asthmatic airway epithelia
por: Pat, Yagiz, et al.
Publicado: (2022)

The use of in vitro human airway epithelia for the development of novel antivirals
por: Huang, S., et al.
Publicado: (2016)

410: Pseudomonas aeruginosa modulates SARS-CoV-2 infectivity in CF airway epithelial cells by increasing expression of the host protease TMPRSS2
por: Ruffin, M., et al.
Publicado: (2021)

Type I IFN immunoprofiling in COVID-19 patients
por: Trouillet-Assant, Sophie, et al.
Publicado: (2020)

SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia
por: Bertrand, Carol A., et al.
Publicado: (2009)

Impaired Ciliogenesis in differentiating human bronchial epithelia exposed to non-Cytotoxic doses of multi-walled carbon Nanotubes
por: Snyder, Ryan J., et al.
Publicado: (2017)

Cell function and identity revealed by comparative scRNA-seq analysis in human nasal, bronchial and epididymis epithelia
por: Paranjapye, Alekh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pq5p7g20b13oo77vkrqfoq8ct4